CG Oncology, Inc. Common stock
CGON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $2 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -88.6% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 5.3% | – | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,604.6% | – | -81,115.4% | -8,344.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,629.5% | – | -66,253.8% | -6,973.2% |
| EPS Diluted | -0.57 | -0.54 | -0.45 | -0.49 |
| % Growth | -5.6% | -20% | 8.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |